AI-powered Light Microcontrollers Driving the Future of Smarter, Safer Automotive Innovation

AI-powered Light Microcontrollers Driving the Future of Smarter, Safer Automotive Innovation

Navigating Tariff Challenges: China’s Strategic Use of EV Patent Power to Expand Market Reach

Navigating Tariff Challenges: China’s Strategic Use of EV Patent Power to Expand Market Reach

Understanding the FDA’s Ambitious Plan to Eliminate Animal Testing in Drug Development

Understanding the FDA’s Ambitious Plan to Eliminate Animal Testing in Drug Development

CarbonScape Secures U.S. Patent for Biochar-Based Graphite, Paving the Way for Sustainable Battery Supply Chains

CarbonScape Secures U.S. Patent for Biochar-Based Graphite, Paving the Way for Sustainable Battery Supply Chains

FDA Approves AbbVie & Pfizer’s Emblaveo for cIAI Amid Rising AMR Concerns

FDA Approves AbbVie & Pfizer’s Emblaveo for cIAI Amid Rising AMR Concerns

FDA Bans Red Dye 3: A Long-Awaited Move to Enhance Consumer Safety

FDA Bans Red Dye 3: A Long-Awaited Move to Enhance Consumer Safety

Eli Lilly Partners with Alchemab Therapeutics to Revolutionize ALS Therapies

Eli Lilly Partners with Alchemab Therapeutics to Revolutionize ALS Therapies

FDA Approves Hikma’s Generic Version of GLP-1 Diabetes Drug Victoza

FDA Approves Hikma’s Generic Version of GLP-1 Diabetes Drug Victoza

Breakthrough in Hydrogel Semiconductors Drives Next-Gen Bioelectronics and Wearable Health Tech

Breakthrough in Hydrogel Semiconductors Drives Next-Gen Bioelectronics and Wearable Health Tech

EU Invests ∼€55 Million in Green Hydrogen Sector to Boost Clean Industrialisation in Namibia

EU Invests ∼€55 Million in Green Hydrogen Sector to Boost Clean Industrialisation in Namibia

US Administration Announces $62 Million Investment to Propel the Hydrogen Industry’s Growth

US Administration Announces $62 Million Investment to Propel the Hydrogen Industry’s Growth

FDA Approves First Device to Enable Automated Insulin Dosing for Individuals with Type 2 Diabetes

FDA Approves First Device to Enable Automated Insulin Dosing for Individuals with Type 2 Diabetes

BASF Settles PFAS Lawsuit for $316 Million

BASF Settles PFAS Lawsuit for $316 Million

Biocon, Biomm: Diabetes Drug Licensing Deal for Brazil

Biocon, Biomm: Diabetes Drug Licensing Deal for Brazil

Huawei aids Europe’s zero-carbon goal with residential energy solution

Huawei aids Europe’s zero-carbon goal with residential energy solution

Contact Us